0001654954-22-001174.txt : 20220204
0001654954-22-001174.hdr.sgml : 20220204
20220204193847
ACCESSION NUMBER: 0001654954-22-001174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazar Andrew Paul
CENTRAL INDEX KEY: 0001727393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 22595189
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD
STREET 2: SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2022-02-02
false
0001645469
Monopar Therapeutics
MNPR
0001727393
Mazar Andrew Paul
1000 SKOKIE BLVD
SUITE 350
WILMETTE
IL
60091
true
true
false
Chief Scientific Officer
Stock Options
2.80
2022-02-02
4
A
false
88874
0
A
2032-02-01
Common Stock
88874
88874
D
Restricted Stock Units
0
2022-02-02
4
A
false
67251
0
A
Common Stock
67251
90398
D
Options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter.
RSUs vest 6/48ths on June 30, 2022 and 3/48ths per quarter thereafter (September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025, December 31, 2025)
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2022-02-04